Lujun Shen

1.8k citations

95 papers · 1.2k indexed · h-index 20

Impact in

Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
Otorhinolaryngology top 2%
- Head and Neck Cancer Studies

Papers in ⓘ

Hepatology 42
- Hepatocellular Carcinoma Treatment and Prognosis 41
Oncology 29
- Cancer Immunotherapy and Biomarkers 13
- Lung Cancer Research Studies 7

Co-authors: Peihong Wu (27 shared papers)Qifeng Chen (22 shared papers)Wang Li (20 shared papers)Tao Huang (26 shared papers)Weijun Fan (33 shared papers)Shuanggang Chen (32 shared papers)Boyang Chang (7 shared papers)Zilin Huang (8 shared papers)
Journals: International Journal of Hyperthermia (6 papers)Frontiers in Oncology (5 papers)Medicine (3 papers)Cancer Immunology Immunotherapy (3 papers)Frontiers in Immunology (2 papers)
Partner nations: China United States Japan

In The Last Decade

Lujun Shen

85 papers receiving 1.2k citations

Peers

Countries citing papers authored by Lujun Shen

Since Specialization

Citations

This map shows the geographic impact of Lujun Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lujun Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lujun Shen more than expected).

Fields of papers citing papers by Lujun Shen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lujun Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lujun Shen. The network helps show where Lujun Shen may publish in the future.

Co-authors

The 25 scholars most cited alongside Lujun Shen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lujun Shen Line = papers co-authored together Lujun Shen links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 95 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	The correlation and prognostic value of serum levels of soluble programmed death protein 1 (sPD-1) and soluble programmed death-ligand 1 (sPD-L1) in patients with hepatocellular carcinoma Cancer Immunology Immunotherapy ·Boyang Chang, Tao Huang, Huajun Wei, Lujun Shen, Duo Zhu, Wenjun He, Qifeng Chen, Huihua Zhang, Yunjian Li, Ruo‐Pan Huang, Wang Li, Peihong Wu	2018	100
2	The m6A methyltransferase METTL3 cooperates with demethylase ALKBH5 to regulate osteogenic differentiation through NF-κB signaling Molecular and Cellular Biochemistry ·Jinjin Yu, Lujun Shen, Yanli Liu, Ming Hong, Xinxing Zhu, Maoping Chu, Juntang Lin	2019	73
3	Frequent amplification of HDAC genes and efficacy of HDAC inhibitor chidamide and PD-1 blockade combination in soft tissue sarcoma Journal for ImmunoTherapy of Cancer ·Yi Que, Xiao-Long Zhang, Zexian Liu, Jingjing Zhao, Qiuzhong Pan, Xizhi Wen, Wei Xiao, Bu-Shu Xu, Dong‐Chun Hong, Tianhui Guo, Lujun Shen, Weijun Fan, Huoying Chen, Desheng Weng, Hairong Xu, Penghui Zhou, Yizhuo Zhang, Xiaohui Niu, Xing Zhang	2021	67
4	Identification and Validation of a Prognostic lncRNA Signature for Hepatocellular Carcinoma Frontiers in Oncology ·Wang Li, Qifeng Chen, Tao Huang, Peihong Wu, Lujun Shen, Zilin Huang	2020	49
5	M1 Stage Subdivision and Treatment Outcome of Patients With Bone-Only Metastasis of Nasopharyngeal Carcinoma The Oncologist ·Lujun Shen, Jun Dong, Sheng Li, Yue Wang, Annan Dong, Wanhong Shu, Ming‐Fang Wu, Changchuan Pan, Yunfei Xia, Peihong Wu	2015	44
6	Combined transarterial chemoembolization and microwave ablation versus transarterial chemoembolization in BCLC stage B hepatocellular carcinoma Diagnostic and Interventional Radiology ·Rusi Zhang, Lujun Shen, Long Zhao, Zhaoming Guan, Qifeng Chen, Wang Li	2018	42
7	High number of PD‐1 positive intratumoural lymphocytes predicts survival benefit of cytokine‐induced killer cells for hepatocellular carcinoma patients Liver International ·Boyang Chang, Lujun Shen, Kefeng Wang, Jietian Jin, Tao Huang, Qifeng Chen, Wang Li, Peihong Wu	2018	32
8	Cryoablation combined with transarterial infusion of pembrolizumab (CATAP) for liver metastases of melanoma: an ambispective, proof-of-concept cohort study Cancer Immunology Immunotherapy ·Lujun Shen, Han Qi, Shuanggang Chen, Fei Cao, Lin Xie, Ying Wu, Weimei Ma, Ze Song, Hui Yuan, Tao Zhang, Dandan Li, Xizhi Wen, Qifeng Chen, Wang Li, Xiaoshi Zhang, Weijun Fan	2020	31
9	Image-based Multilevel Subdivision of M1 Category in TNM Staging System for Metastatic Nasopharyngeal Carcinoma Radiology ·Lujun Shen, Wang Li, Siyang Wang, Guofeng Xie, Qi Zeng, Chen Chen, Feng Shi, Ying Zhang, Ming‐Fang Wu, Wanhong Shu, Changchuan Pan, Yunfei Xia, Peihong Wu	2016	28
10	Alternative splicing events are prognostic in hepatocellular carcinoma Aging ·Qifeng Chen, Wang Li, Peihong Wu, Lujun Shen, Zi-Lin Huang	2019	28
11	Investigating Mechanisms of Response or Resistance to Immune Checkpoint Inhibitors by Analyzing Cell-Cell Communications in Tumors Before and After Programmed Cell Death-1 (PD-1) Targeted Therapy: An Integrative Analysis Using Single-cell RNA and Bulk-RNA Sequencing Data OncoImmunology ·Yiquan Jiang, Zixian Wang, Ming Zhong, Lujun Shen, Xue Han, Xuxiazi Zou, Xin-Yi Liu, Yinan Deng, Yang Yang, Guihua Chen, Wuguo Deng, Jinhua Huang	2021	26
12	A Prognostic Nomogram Incorporating Depth of Tumor Invasion to Predict Long-term Overall Survival for Tongue Squamous Cell Carcinoma With R0 Resection Journal of Cancer ·Boyang Chang, Wenjun He, Hui Ouyang, Jingwen Peng, Lujun Shen, Anxun Wang, Peihong Wu	2018	26
13	Dynamically prognosticating patients with hepatocellular carcinoma through survival paths mapping based on time-series data Nature Communications ·Lujun Shen, Qi Zeng, Pi Guo, Jingjun Huang, Chaofeng Li, Tao Pan, Boyang Chang, Nan Wu, Lewei Yang, Qifeng Chen, Tao Huang, Wang Li, Peihong Wu	2018	25
14	Examining the key genes and pathways in hepatocellular carcinoma development from hepatitis B virus‑positive cirrhosis Molecular Medicine Reports ·Qifeng Chen, Jin‐Guo Xia, Wang Li, Lujun Shen, Tao Huang, Peihong Wu	2018	22
15	Combined CT-guided radiofrequency ablation with systemic chemotherapy improves the survival for nasopharyngeal carcinoma with oligometastasis in liver: Propensity score matching analysis Oncotarget ·Wang Li, Yutong Bai, Ming‐Fang Wu, Lujun Shen, Feng Shi, Xuqi Sun, Cai‐Jin Lin, Boyang Chang, Changchuan Pan, Zhiwen Li, Peihong Wu	2016	21
16	Percutaneous CT-guided radiofrequency ablation for patients with extrahepatic oligometastases of hepatocellular carcinoma: long-term results International Journal of Hyperthermia ·Luwen Mu, Lin Sun, Tao Pan, Ning Lyu, Shaolong Li, Xishan Li, Jianpeng Wang, Qiankun Xie, Haijing Deng, Lie Zheng, Jianhong Peng, Lujun Shen, Weijun Fan, Peihong Wu, Ming Zhao	2017	21
17	Cryoablation reshapes the immune microenvironment in the distal tumor and enhances the anti-tumor immunity Frontiers in Immunology ·Ying Wu, Fei Cao, Danyang Zhou, Shuanggang Chen, Han Qi, Tao Huang, Hongtong Tan, Lujun Shen, Weijun Fan	2022	20
18	Significance of tumor-infiltrating immunocytes for predicting prognosis of hepatitis B virus-related hepatocellular carcinoma World Journal of Gastroenterology ·Qifeng Chen, Wang Li, Peihong Wu, Lujun Shen, Zilin Huang	2019	20
19	Microwave ablation after downstaging of hepatocellular carcinoma: outcome was similar to tumor within Milan criteria European Radiology ·Feng Shi, Shanshan Lian, Qicong Mai, Zhiqiang Mo, Wenhang Zhuang, Wei Cui, Lujun Shen, Chen Meng, Peihong Wu, Xiaoming Chen	2020	20
20	Trajectories of serum α-fetoprotein and intermediate-stage hepatocellular carcinoma outcomes after transarterial chemoembolization: A longitudinal, retrospective, multicentre, cohort study EClinicalMedicine ·Linbin Lu, Lujun Shen, Zhixian Wu, Yanhong Shi, Peifeng Hou, Zengfu Xue, Cheng Lin, Xiong Chen	2022	19

About Lujun Shen

Lujun Shen is a scholar working on Hepatology, Oncology, Pulmonary and Respiratory Medicine, Surgery and Epidemiology, having authored 95 papers that have together received 1.2k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (41 papers), Liver Disease Diagnosis and Treatment (17 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (15 papers), Cancer Immunotherapy and Biomarkers (13 papers), Head and Neck Cancer Studies (8 papers), Lung Cancer Research Studies (7 papers), Renal cell carcinoma treatment (6 papers) and Immunotherapy and Immune Responses (6 papers). The work is most often cited by research in Hepatology (372 citations), Otorhinolaryngology (139 citations), Cancer Research (258 citations), Oncology (408 citations) and Pulmonary and Respiratory Medicine (306 citations). Lujun Shen has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Peihong Wu, Qifeng Chen, Wang Li, Tao Huang, Weijun Fan, Shuanggang Chen, Boyang Chang, Zilin Huang, Han Qi and Ying Wu. Their work appears in journals such as International Journal of Hyperthermia, Frontiers in Oncology, Medicine, Cancer Immunology Immunotherapy and Frontiers in Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact